Related Experiment Video
Updated: Dec 28, 2025

Author Spotlight: Quantitative Detection of DNA Protein Crosslinks and Their Post-Translational Modifications
Published on: April 21, 2023
Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity
Nicholas Sciascia1,2, Wei Wu1, Dali Zong1
1Laboratory of Genome Integrity, National Institutes of Health, Bethesda, United States.
Abstract:
Topoisomerase II (TOP2) relieves topological stress in DNA by introducing double-strand breaks (DSBs) via a transient, covalently linked TOP2 DNA-protein intermediate, termed TOP2 cleavage complex (TOP2cc). TOP2ccs are normally rapidly reversible, but can be stabilized by TOP2 poisons, such as the chemotherapeutic agent etoposide (ETO). TOP2 poisons have shown significant variability in their therapeutic effectiveness across different cancers for reasons that remain to be determined. One potential explanation for the differential cellular response to these drugs is in the manner by which cells process TOP2ccs. Cells are thought to remove TOP2ccs primarily by proteolytic degradation followed by DNA DSB repair. Here, we show that proteasome-mediated repair of TOP2cc is highly error-prone. Pre-treating primary splenic mouse B-cells with proteasome inhibitors prevented the proteolytic processing of trapped TOP2ccs, suppressed the DNA damage response (DDR) and completely protected cells from ETO-induced genome instability, thereby preserving cellular viability. When degradation of TOP2cc was suppressed, the TOP2 enzyme uncoupled itself from the DNA following ETO washout, in an error-free manner. This suggests a potential mechanism of developing resistance to topoisomerase poisons by ensuring rapid TOP2cc reversal.
Insights
Proteasome inhibitors prevent error-prone repair of Topoisomerase II (TOP2) cleavage complexes (TOP2ccs). Suppressing TOP2cc degradation protects cells from DNA damage and genome instability, suggesting a resistance mechanism to TOP2 poisons.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- Topoisomerase II (TOP2) manages DNA topology by creating transient double-strand breaks (DSBs) through TOP2 cleavage complexes (TOP2ccs).
- TOP2ccs are reversible but can be stabilized by poisons like etoposide (ETO), leading to variable therapeutic effectiveness in cancer.
- Cellular responses to TOP2 poisons may depend on how TOP2ccs are processed, primarily through proteolytic degradation and DNA repair.
Purpose of the Study:
- To investigate the role of proteasome-mediated repair in processing TOP2 cleavage complexes (TOP2ccs).
- To determine if inhibiting proteasome activity affects cellular response to TOP2 poisons like etoposide (ETO).
- To explore a potential mechanism for resistance to topoisomerase poisons.
Main Methods:
- Primary splenic mouse B-cells were pre-treated with proteasome inhibitors.
- Cells were subsequently exposed to the TOP2 poison etoposide (ETO).
- Analysis of TOP2cc processing, DNA damage response (DDR), genome instability, and cellular viability.
Main Results:
- Proteasome inhibition prevented proteolytic processing of trapped TOP2ccs.
- Suppression of TOP2cc degradation inhibited the DNA damage response (DDR).
- Cells protected from etoposide-induced genome instability and preserved viability; TOP2 uncoupled error-free from DNA upon ETO washout.
Conclusions:
- Proteasome-mediated repair of TOP2ccs is an error-prone process.
- Inhibiting proteasome activity protects cells from TOP2 poison-induced genotoxicity.
- Suppression of TOP2cc degradation offers a potential strategy for developing resistance to topoisomerase poisons.
More Related Videos
Related Concept Videos
DNA Topoisomerases
Types and Mechanism of action
Topoisomerases are divided into two main types. ...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Abnormal Proliferation
Replicative Cell Senescence
Negative Regulator Molecules

